Form 4: Definitive Healthcare Corp. CEO Kevin Coop Acquires 186,192 Shares of Class A Common Stock

Sentiment:

SEC Form 4 Filing


Definitive Healthcare Corp.'s CEO, Kevin Coop, reports the acquisition of 186,192 shares of Class A Common Stock on July 4, 2024, bringing his total holdings to 1,356,239 shares.

Summary

  • On July 4, 2024, Kevin Coop, the CEO of Definitive Healthcare Corp., acquired 186,192 shares of Class A Common Stock.
  • The acquisition was made at a price of $0 per share.
  • Following the transaction, Coop directly owns 1,356,239 shares of Class A Common Stock.
  • The report also mentions restricted stock units (RSUs) that vest over time, starting July 1, 2025, with 25% vesting initially and the remainder vesting quarterly over three years, contingent upon continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CEO increasing their stake in the company is generally viewed favorably, suggesting confidence in the company's prospects. However, the filing itself is a routine regulatory disclosure.

Positives

  • The CEO's acquisition of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the restricted stock units indicates a long-term commitment from the CEO, with vesting occurring over a three-year period following the initial vesting date of July 1, 2025.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of shares by the CEO is a common occurrence and can be seen as a sign of confidence in the company's future.

Stakeholder Impact

  • The CEO's increased ownership stake could positively influence shareholder sentiment.
  • Employees may view the CEO's investment as a positive sign for the company's future.

Key Dates

DateDescription
07/04/2024Date of transaction: Kevin Coop acquired 186,192 shares of Class A Common Stock.
07/01/2025Initial vesting date for 25% of the restricted stock units (RSUs).
07/08/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.